Access to Medicine: Pharmaceutical Patents and Public Health Needs Under the WTO Framework

DSpace/Manakin Repository

Access to Medicine: Pharmaceutical Patents and Public Health Needs Under the WTO Framework

Show simple item record

dc.contributor.advisor Peter Hutt en_US
dc.contributor.author Liu, Kuanling
dc.date.accessioned 2012-07-06T22:06:28Z
dc.date.issued 2008
dc.identifier.citation Kuanling Liu, Access to Medicine: Pharmaceutical Patents and Public Health Needs Under the WTO Framework (April 2008). en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965623
dc.description.abstract Many people, particularly in developing countries, die from curable or manageable diseases without access to medicine. After the TRIPS Agreement was brought into force, access to medicine in developing countries became worse and even deteriorated development. To solve the controversy in interpreting the TRIPS Agreement and the resulting public health crises, the Doha Declaration was adopted, recognizing the flexibilities of the TRIPS Agreement as effective and vital manners to promote access to medicines. However, there are still many difficulties encountered by developing countries in full implementation of the Doha Declaration. Therefore, this paper aims to reexamine and reaffirm access to medicine as an international human right, claiming it should be accommodated under the WTO framework, and also proposes several possible solutions to advance the accessibility of medicine. en_US
dash.license LAA
dc.subject.other Food and Drug Law en_US
dc.title Access to Medicine: Pharmaceutical Patents and Public Health Needs Under the WTO Framework en_US
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T22:06:28Z

Files in this item

Files Size Format View
Kuanling Liu Course and LLM work requirement.pdf 360.0Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters